A New Code for Pharmaceutical Marketing Practices: From Symptoms to Diagnosis

Pursuant to a notification dated March 12, 2024, the Department of Pharmaceuticals under India’s Ministry of Chemicals and Fertilizers issued a new uniform code for pharmaceutical marketing practices (the “New Code”), replacing a decade-old version of the same code (the “Old Code”).
The New Code applies to both pharmaceutical and medical device companies and aims to provide operational clarity around promotional activities undertaken by such companies. Although several key themes of the Old Code have been retained, a more balanced approach with respect to educational events and items has been introduced. Further, while it has been generally strengthened relative to the Old Code – including in respect of penalties, complaints and appeals, along with the possibility of future standing orders – the New Code remains voluntary, although an explicit reference to its voluntary nature has now been omitted.


Model Concession Agreements: Paving the Path to Increased Public-Private Partnership

The note discusses recent amendments issued by the Ministry of Road, Transport and Highways, Government of India to the model concession agreements for build-operate-toll (BOT) and toll-operate-transfer (TOT) road projects, which are expected to ease certain practical challenges under the BOT and TOT models and increase public-private partnerships in the roads sector in India.


Abhishek Singh

S&R Associates Welcomes New Counsel

We are pleased to announce that Abhishek Singh has joined S&R Associates as counsel based in the Firm’s Mumbai office. He joins us in our regulatory practice after working for 15 years at the Securities and Exchange Board of India (SEBI).